DUBIN STEVE
SEC CIK 1265123 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | Dir | 22.7K | $12.0K | — | 4 | 2023-06-01 | 2025-06-11 |
Most active insiders at ACET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $5.00M | $674.8K |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 10% | $1.60M | — |
| 3 | Aftab Blake | CSO | — | — |
| 4 | Healey Don | CTO | — | — |
| 5 | Harvey Brian Nicholas | CFO | — | — |
| 6 | Schor Chen | Pres, CEO, Dir | — | — |
DUBIN STEVE made no open-market trades at ACET in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-13 | 2025-06-11 | ACET | Adicet Bio, Inc. | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 22.7K | +35% | $0 |
| D | 2024-06-07 | 2024-06-05 | ACET | Adicet Bio, Inc. | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 16.8K | +54% | $0 |
| 2023-06-30 | 2023-06-30 | ACET | Adicet Bio, Inc. | DUBIN STEVE | Dir | P - Purchase | $2.40 | +5,000 | 10.9K | +85% | +$12.0K | |
| D | 2023-06-02 | 2023-06-01 | ACET | Adicet Bio, Inc. | DUBIN STEVE | Dir | A - Grant | $0.00 | +5,900 | 5,900 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations